Impact of cardiovascular risk factors on severity of peripheral artery disease

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 97-101

  Wyss, Thomas R ^a   Adam, Luise ^a   Haynes, Alan G ^b   Kucher, Nils ^a   Silbernagel, Guenther ^a   Do, Dai Do ^a   Schmidli, Juerg ^a   Baumgartner, Iris ^a  

^a PSI   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Age; Diabetes mellitus; Diabetic vascular disease; Peripheral artery disease; Renal insufficiency

Indexed keywords

AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CRITICAL LIMB ISCHEMIA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOVASCULAR SURGERY; FEMALE; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; SMOKING; TERTIARY CARE CENTER; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DYSLIPIDEMIAS; ISCHEMIA; LEG; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; VASCULARIZATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DYSLIPIDEMIAS; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING;

EID: 84937020041     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.07.002     Document Type: Article

References (26)

1. Murabito J.M., D'Agostino R.B., Silbershatz H., Wilson W.F. Intermittent claudication. A risk profile from the Framingham Heart Study. Circulation 1997, 96:44-49.
2. Brand F.N., Abbott R.D., Kannel W.B. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989, 38:504-509.
3. Diehm N., Shang A., Silvestro A., et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2006, 31:59-63.
4. Joosten M.M., Pai J.K., Bertoia M.L., et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. J.Am. Med. Assoc. 2012, 308:1660-1667.
5. Fowkes F.G., Rudan D., Rudan I., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, 382:1329-1340.
6. Berger J.S., Hochman J., Lobach I., Adelman M.A., Riles T.S., Rockman C.B. Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories. J.Vasc. Surg. 2013, 58. 673-81 e1.
7. Cacoub P.P., Abola M.T., Baumgartner I., et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009, 204:e86-92.
8. Golomb B.A., Dang T.T., Criqui M.H. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006, 114:688-699.
9. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J.Vasc. Surg. 2007, 45(Suppl.S):S5-S67.
10. Becker F., Robert-Ebadi H., Ricco J.B., et al. Chapter I: definitions, epidemiology, clinical presentation and prognosis. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2011, 42(Suppl.2):S4-S12.
11. Chung J., Timaran D.A., Modrall J.G., et al. Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia. J.Vasc. Surg. 2013, 58:972-980.
12. Belch J., Hiatt W.R., Baumgartner I., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377:1929-1937.
13. Mahoney E.M., Wang K., Keo H.H., et al. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ. Cardiovasc. Qual. Outcomes 2010, 3:642-651.
14. Chung J., Modrall J.G., Valentine R.J. The need for improved risk stratification in chronic critical limb ischemia. J.Vasc. Surg. 2014 Dec, 60(6):1677-1685.
15. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 2006, 145:247-254.
16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2002, 39:S1-S266.
17. Diehm C., Schuster A., Allenberg J.R., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004, 172:95-105.
18. Cacoub P., Cambou J.P., Kownator S., et al. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int. J. Clin. Pract. 2009, 63:63-70.
19. Signorelli S.S., Fiore V., Mangiafico M., Castrogiovanni D. Arterial plaques in peripheral arteries diagnosed by ultrasound in a cohort of patients with type 2 diabetes mellitus: a single-center surveillance. Angiology 2014 Sep 14, pii:0003319714548443. [Epub ahead of print].
20. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
21. O'Hare A.M., Glidden D.V., Fox C.S., Hsu C.Y. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004, 109:320-323.
22. Selvin E., Kottgen A., Coresh J. Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. Eur. Heart J. 2009, 30:1918-1925.
23. Willenberg T., Baumann F., Eisenberger U., Baumgartner I., Do D.D., Diehm N. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. J.Vasc. Surg. 2011, 53:1589-1597.
24. Fowkes F.G., Housley E., Riemersma R.A., et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am. J. Epidemiol. 1992, 135:331-340.
25. Price J.F., Mowbray P.I., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 1999, 20:344-353.
26. Hirsch A.T., Allison M.A., Gomes A.S., et al. Acall to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2012, 125:1449-1472.